Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1998 1
2001 1
2002 1
2011 2
2012 1
2013 1
2014 1
2016 1
2018 1
2019 2
2020 4
2021 5
2022 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
The Present and Future of Postmastectomy Radiation.
Ohri N, George M, Omene C, Haffty B. Ohri N, et al. Among authors: omene c. Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):466-467. doi: 10.1016/j.ijrobp.2023.10.002. Int J Radiat Oncol Biol Phys. 2024. PMID: 38220259 No abstract available.
Clinical efficacy of PARP inhibitors in breast cancer.
Pandya K, Scher A, Omene C, Ganesan S, Kumar S, Ohri N, Potdevin L, Haffty B, Toppmeyer DL, George MA. Pandya K, et al. Among authors: omene c. Breast Cancer Res Treat. 2023 Jul;200(1):15-22. doi: 10.1007/s10549-023-06940-0. Epub 2023 May 2. Breast Cancer Res Treat. 2023. PMID: 37129747 Review.
Ovarian Suppression: Early Menopause, Late Effects.
Goldberg C, Greenberg MR, Noveihed A, Agrawal L, Omene C, Toppmeyer D, George MA. Goldberg C, et al. Among authors: omene c. Curr Oncol Rep. 2024 May;26(5):427-438. doi: 10.1007/s11912-023-01491-5. Epub 2024 Jan 2. Curr Oncol Rep. 2024. PMID: 38305992 Review.
Psychiatric and affective predictors of negative racial attitudes.
Kimhy D, Ospina LH, Beck-Felts K, Lister A, Omene C, Bodenhausen G, Mittal V. Kimhy D, et al. Among authors: omene c. Psychiatry Res. 2023 Sep;327:115376. doi: 10.1016/j.psychres.2023.115376. Epub 2023 Jul 30. Psychiatry Res. 2023. PMID: 37531817
30 results